Evidence supporting the use of: SOD (Superoxide Dismutase, antioxidant activity)
For the health condition: Lou Gehrig's Disease
Synopsis
Source of validity: Scientific
Rating (out of 5): 2
Superoxide dismutase (SOD) is an enzyme that plays a crucial role in protecting cells from oxidative damage by catalyzing the conversion of superoxide radicals into oxygen and hydrogen peroxide. Lou Gehrig’s Disease, or amyotrophic lateral sclerosis (ALS), is characterized in part by increased oxidative stress and damage to motor neurons. Notably, mutations in the gene encoding Cu/Zn SOD (SOD1) are responsible for a subset of familial ALS cases, linking the enzyme directly to disease mechanisms. This has led to scientific interest in SOD as a potential therapeutic agent for ALS. However, clinical trials evaluating SOD supplementation (usually bovine-derived SOD or synthetic mimetics) have produced disappointing results. For example, a randomized controlled trial (Appel et al., 1995, NEJM) found that intravenous bovine SOD did not slow ALS progression compared to placebo. Additionally, the bioavailability of orally administered SOD is extremely low, as the enzyme is degraded in the gastrointestinal tract. Despite its biological plausibility and direct genetic connection to ALS pathology, no robust evidence supports SOD supplementation as a beneficial therapy in ALS patients. The overall quality and quantity of evidence is low, and mainstream guidelines do not recommend SOD for ALS treatment. Research continues into SOD1-targeted therapies (such as antisense oligonucleotides), but not SOD enzyme supplementation itself. Thus, the evidence rating is 2/5, indicating initial scientific rationale but insufficient clinical benefit demonstrated.
More about SOD (Superoxide Dismutase, antioxidant activity)
More about Lou Gehrig's Disease
Other health conditions supported by SOD (Superoxide Dismutase, antioxidant activity)
Aging (prevention)Alzheimer's Disease
Arthritis
Asthma
Cancer (natural therapy for)
Cancer (prevention)
Cancer Treatment (reducing side effects)
Cardiovascular Disease
Chemotherapy (reducing side effects)
Chronic Obstructive Pulmonary Disorder
Conjunctivitis
Convalescence
Dementia
Depression
Diabetes
Diabetic Retinopathy
Emphysema
Exercise
Fatigue
Fibrosis
Free Radical Damage
Gingivitis
Heart (weakness)
Hepatitis
Hypertension
Inflammation
Inflammatory Bowel Disorders
Liver Detoxification
Lou Gehrig's Disease
Macular Degeneration
Memory and Brain Function
Nerve Damage
Rheumatoid Arthritis
Strokes
Wounds and Sores
Wrinkles